Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 149.53 | N/A |
| PEG Ratio (TTM) | -2.27 | N/A |
| P/S Ratio (TTM) | 3.07 | N/A |
| P/B Ratio (TTM) | 4.46 | N/A |
| P/FCF Ratio (TTM) | 32.81 | N/A |
| Price to 5YR AVG Earnings Ratio | 43.71 | N/A |
| Price to 5YR AVG FCF Ratio | 51.70 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.49% | N/A |
| ROE (TTM) | 2.92% | N/A |
| Net Profit Margin (TTM) | 2.09% | N/A |
| ROIC 5YR AVG | 13.32% | N/A |
Growth (28%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -24.59% | 4.18% | 3.15% |
| Revenue | 0.60% | 0.57% | 2.80% |
| Net Income | 41.25% | 3.86% | 2.24% |
| Cash Flow | -24.27% | -33.92% | 60.85% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.54 | N/A |
| Quick Ratio (TTM) | 2.72 | N/A |
| D/E Ratio (TTM) | 0.55 | N/A |
| Interest Coverage (TTM) | 1.93 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.18 | N/A |
| LTL to 5YR AVG FCF | 0.89 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.45% | N/A |